Treatment of Chronic Hepatitis B in 2002

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F03%3A00007828" target="_blank" >RIV/65269705:_____/03:00007828 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Treatment of Chronic Hepatitis B in 2002

Original language description

Viral hepatitis B is one of the most serious health problems of recent period, above all in the world?s developing countries. It is estimated that two billion people will be infected with the hepatitis B virus in the course of their lives and between 350and 400 million people are chronically infected at present. The aims of the treatment of chronic hepatitis B are to achieve sustained suppression of viral replication and remission of liver disease. For the treatment of chronic hepatitis B two drugs have been licensed worldwide: alpha-interferon and lamivudine. The third potent drug, adefovir dipivoxil, is now approved only in the United States. In chronic hepatitis B therapy there are new and exciting developments in antiviral, such as nucleoside analogs - entecavir, emtricitabine, clevudine, beta-L-nucleosides. Studies, comparing pegylated interferon with lamivudine and with combination of lamivudine and pegylated interferon are in progress. Several innovative antiviral approaches ha

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FN - Epidemiology, infection diseases and clinical immunology

OECD FORD branch

—

Project

<a href="/en/project/NI7484" target="_blank" >NI7484: Dependence of sustained virological response on the early viral kinetics in the treatment of chronic hepatitis C patients with combination of alpha-interferon, or pegylated interferon, and ribavirin.</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2003

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Bratislavské lekárské listy

ISSN

0006-9248

e-ISSN

—

Volume of the periodical

104

Issue of the periodical within the volume

2

Country of publishing house

SK - SLOVAKIA

Number of pages

5

Pages from-to

59-63

UT code for WoS article

—

EID of the result in the Scopus database

—